Liver cirrhosis trials in Brazil
4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Belo Horizonte, Brasília, Goiânia, Porto Alegre
- Age
- 18 years to 80 years
- People
- 2,150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - Phase 3Taking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Barra, Belém, Belo Horizonte, Botucatu, Cerqueira César, Porto Alegre, São José do Rio Preto, São Paulo
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Barretos, Belo Horizonte, Botucatu, Brasília, Goiânia, Porto Alegre, Rio de Janeiro, Salvador, São José do Rio Preto, São Paulo, Vitória
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - No phaseTaking peopleLiver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Where
- Fortaleza, Porto Alegre, São Paulo
- Age
- 18 years to 80 years
- People
- 3,000 worldwide
- Run by
- European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921